abstract |
A pharmaceutical composition for the treatment of cardiac arrhythmia comprising anneffective anti-arrhythmic amount of the compound in association with a pharmaceuticallynacceptable, substantially non-toxic carrier or excipient, and methods for the treatment ofncardiac arrhythmia or effecting anti-arrhythmic action which comprise administering to anpatient requiring anti-arrhythmic therapy or effect the compound. |